Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Methods of Medium Optimization01:28

Methods of Medium Optimization

Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Decision Making: P-value Method01:09

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Michigan Sibling Immunity Birth Study (M-SIBS): Study design protocol for a unique food allergy birth cohort.

The journal of allergy and clinical immunology. Global·2026
Same author

Improving Healthcare Efficiency and Patient Outcomes Through Proactive Insight to Action: A Sickle Cell Disease Case Example.

Journal of patient experience·2025
Same author

An Intriguing Case of Non-typhoidal Salmonella Presenting as Bacteremia and Bilateral Cellulitis in a Diabetic Patient.

Cureus·2025
Same author

Phenotypically driven subgroups of ASD display distinct metabolomic profiles.

Brain, behavior, and immunity·2023
Same author

Pursuing Elimination of Hepatitis C in Egypt: Cost-Effectiveness and Economic Evaluation of a Country-Wide Program.

Infectious diseases and therapy·2022
Same author

Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures.

American journal of medical genetics. Part A·2022

Related Experiment Videos

Optimizing medical device buying. Value analysis models can help you improve decision-making process.

Josh Feldstein1, Elizabeth Brooks

  • 1Marcom Group International Inc, Bethel, CT, USA.

Materials Management in Health Care
|July 3, 2010
PubMed
Summary

Value Analysis Models (VAMs) assist healthcare professionals in making informed purchasing decisions by providing comparative value assessments. These models facilitate easier product acquisition without declaring one product superior to another.

Related Experiment Videos

Area of Science:

  • Healthcare Management
  • Health Economics
  • Materials Management

Background:

  • Value Analysis Models (VAMs) are emerging as crucial tools in healthcare.
  • Manufacturers increasingly support VAMs to provide data to customers and the industry.

Purpose of the Study:

  • To introduce Value Analysis Models (VAMs) as an analytical tool for healthcare purchasing.
  • To highlight the role of VAMs in comparative value assessments.

Main Methods:

  • The study focuses on the conceptual framework and application of VAMs.
  • It emphasizes the comparative assessment capabilities of these models.

Main Results:

  • VAMs provide a structured approach to evaluating product value.
  • They support informed decision-making for materials and operating room managers, and CFOs.

Conclusions:

  • Value Analysis Models (VAMs) simplify the product acquisition process.
  • VAMs are designed as decision-support tools, not for product superiority claims.